Adamas Pharmaceuticals Inc

NASDAQ:ADMS   9:52:42 AM EDT
8.07
0.00 (-0.06%)
Debt Financing / Related

Adamas Pharmaceuticals Says Amended Terms Of Royalty-Backed Loan Agreement With Healthcare Royalty Partners Extend Maturity Date To March 31, 2027

Published: 12/02/2020 12:28 GMT
Adamas Pharmaceuticals Inc (ADMS) - Adamas Announces Agreement to Amend Royalty-backed Loan Agreement With Healthcare Royalty Partners.
Adamas Pharmaceuticals Inc - Agreement Eliminated Potential Royalty Rate Step-up to 17.5%.
Adamas Pharmaceuticals - Amended Terms of Royalty-backed Loan Agreement With Healthcare Royalty Partners Extend Maturity Date to March 31, 2027.
Adamas Pharmaceuticals Inc - Amendment Will Come Into Effect Upon Closing Acquisition of Osmolex Er in Early 2021.
Adamas - Amended Terms of Deal With Hcr Also Added Covenant Requiring Co to Maintain a Minimum Cash, Investments Balance of $25 Million.